How Common Is MRONJ After Extraction?
For patients taking osteoporosis pills such as Fosamax®, Actonel®, Atelvia®, or Boniva®, the risk of MRONJ after a tooth extraction is estimated at less than 0.15%, or fewer than 1 in 650 patients.
For patients receiving Prolia® (denosumab) injections for osteoporosis, the estimated risk after a tooth extraction is about 1%, or roughly 1 in 100 patients.
The risk is higher for patients receiving Zometa® (zoledronic acid) or Xgeva® (denosumab) as part of cancer treatment. Those medications are usually given more often and at higher doses than osteoporosis medications. Reported MRONJ rates after tooth extraction in this group range from 1.6% to 14.8%.
Other factors affect healing too, including infection, tobacco use, oral hygiene, steroid use, and your general health. Your oral surgeon will weigh all of them when discussing your risk and your options.
What Are the Signs or Symptoms of MRONJ?
MRONJ does not always begin with exposed bone. Many people first notice a dull ache in the jaw, swelling, a loose tooth, or an extraction site that is slow to heal. As it progresses, bone becomes visible through the gums and can feel rough against the tongue. Some patients develop a small opening that does not heal or that drains fluid. A defect or hole may also form that traps food and needs regular cleaning.
Pain, swelling, drainage, or a bad taste can occur if an infection develops. In more advanced cases, MRONJ can cause numbness, small pieces of bone to loosen or break away, or a fracture of the jaw. If you are taking an osteoporosis medication and notice any of these changes, contact us. Early evaluation gives us more options.
If you take or have taken an osteoporosis medication and notice any of these changes, contact our office for an evaluation, even if you do not have pain. Early evaluation can help identify the cause and guide treatment before the problem becomes more extensive.